+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Guide RNA Market - Global Forecast 2026-2032- Product Image
Guide RNA Market - Global Forecast 2026-2032- Product Image
Sale

Guide RNA Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6144255
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Guide RNA Market is projected to reach USD 741.63 Million in 2026. It is expected to continue growing at a CAGR of 10.32%, reaching USD 1.33 Billion by 2032.

Guide RNA Enables More Precise Genome-Editing Workflows

Guide RNA is a programmable nucleic-acid component used to direct CRISPR-associated enzymes toward selected genetic sequences. Its design, synthesis, validation, and integration with delivery systems are central to research and therapeutic genome-editing workflows. Progress in sequence-selection tools, chemical modification, manufacturing, and quality control is improving the reliability of guide RNA-enabled applications while keeping specificity, reproducibility, and biological performance as primary considerations.

Design, Delivery, and Quality Standards Are Reshaping Guide RNA Development

The guide RNA landscape is shifting from proof-of-concept experimentation toward more standardized and application-specific workflows. Researchers are placing greater emphasis on off-target assessment, guide stability, intracellular delivery, batch consistency, and compatibility with different Cas enzymes. Regulatory expectations are also encouraging clearer characterization of identity, purity, potency, and genomic outcomes, particularly where guide RNA is used in advanced therapeutic development.

Artificial Intelligence Accelerates Guide Selection and Experimental Prioritization

Artificial intelligence is being applied to predict guide activity, rank candidate sequences, identify potential off-target sites, and interpret high-throughput screening data. Machine-learning models can help reduce the number of experimental iterations, although their value depends on representative training data, transparent validation, and confirmation in relevant cell and tissue systems. AI therefore functions as a decision-support layer rather than a substitute for laboratory testing, quality controls, or regulatory review.

Regional Ecosystems Differ in Research Infrastructure and Regulatory Readiness

North America combines strong biomedical research capacity, translational infrastructure, and active oversight of genome-editing applications. Europe emphasizes collaborative research, data governance, and stringent product characterization, while the European Union provides a particularly coordinated regulatory context. Asia-Pacific benefits from substantial life-science investment and advanced manufacturing capabilities, with Australia, China, India, Japan, and South Korea representing important research and development environments. Latin America is expanding access to genomic research and specialized laboratory services, with Brazil and Mexico serving as notable hubs. The Middle East is building biotechnology capacity through institutional investment, while Africa’s progress is shaped by infrastructure availability, training, public-health priorities, and partnerships that support locally relevant genomic research.

International Alliances Are Aligning Research, Trade, and Biosafety Priorities

ASEAN members are strengthening regional scientific cooperation while addressing differences in infrastructure and regulatory capacity. BRICS countries span large and diverse research systems, creating opportunities for collaboration in affordable technologies, agricultural applications, and health research. The European Union supports cross-border coordination through shared standards and funding mechanisms. G7 economies contribute advanced research, clinical, and manufacturing capabilities, while GCC countries are investing in biotechnology infrastructure and talent development. NATO members are also relevant to discussions of biosecurity, responsible innovation, and resilience across critical research and health systems.

National Capabilities Range from Platform Innovation to Translational Adoption

The United States and Canada have deep research and clinical-development ecosystems, while the United Kingdom, Germany, France, Italy, and Spain contribute through coordinated European research and regulatory networks. China, Japan, South Korea, India, and Australia combine strong academic or industrial capabilities with growing interest in genomic medicine and biotechnology manufacturing. Brazil and Mexico are expanding research access and specialized capacity in Latin America. Russia maintains scientific capabilities but operates within a distinct institutional and international environment. Across these countries, adoption is influenced by funding, technical talent, ethical oversight, biomanufacturing capacity, and the ability to validate guide performance in relevant biological contexts.

Leaders Should Prioritize Validated Design, Scalable Manufacturing, and Responsible Governance

Industry leaders should establish end-to-end guide RNA quality systems covering sequence design, synthesis, purification, storage, delivery, and functional validation. Investment should focus on orthogonal off-target testing, application-specific performance benchmarks, and interoperable data systems that make experimental results traceable. Organizations can use AI to prioritize candidates while maintaining laboratory confirmation and documented model governance. Partnerships with regional research institutions can improve local validation and workforce development, and early engagement with regulators can clarify expectations for genomic safety, manufacturing controls, and clinical evidence.

Methodology Combines Structured Evidence Review With Geographic and Application Analysis

This executive summary uses the supplied guide RNA market scope as its subject and synthesizes established scientific, regulatory, technological, and geographic themes relevant to the field. The assessment considers guide RNA design and optimization, delivery, manufacturing, quality control, genome-editing applications, artificial intelligence, and institutional readiness. Regional, group, and country perspectives are integrated qualitatively across the required geographies. No market estimates, market sizing, market shares, forecasts, or company-specific claims are used.

Guide RNA Progress Depends on Precision, Reproducibility, and Trustworthy Translation

Guide RNA is becoming an increasingly structured component of genome-editing research and development. Continued progress will depend on combining computational design with rigorous experimental validation, scalable and consistent production, fit-for-purpose delivery, and responsible oversight. Organizations that connect technical performance with transparent governance and regionally informed partnerships will be better positioned to translate guide RNA capabilities into reliable research, therapeutic, agricultural, and industrial applications.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Guide RNA Market, by Product
7.1. Introduction
7.2. In Vitro Transcription
7.3. Synthetic
8. Guide RNA Market, by Type
8.1. Introduction
8.2. Activation
8.3. Interference
8.4. Single Guide
9. Guide RNA Market, by Technology
9.1. Introduction
9.2. CRISPR/Cas12
9.3. CRISPR/Cas13
9.4. CRISPR/Cas9
10. Guide RNA Market, by Application
10.1. Introduction
10.2. Gene Editing
10.3. Gene Regulation
10.4. Gene Sequencing
11. Guide RNA Market, by End User
11.1. Introduction
11.2. Biopharma
11.2.1. Biotechnology Companies
11.2.2. Pharma Companies
11.3. Contract Research Organizations
11.4. Research Institutes
11.4.1. Academic Institutions
11.4.2. Nonprofit Organizations
12. Guide RNA Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Guide RNA Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Guide RNA Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Azenta Life Sciences
16.3. Beam Therapeutics Inc.
16.4. Benchling, Inc.
16.5. Cellecta Inc.
16.6. CRISPR Therapeutics AG
16.7. Dharmacon
16.8. Editas Medicine, Inc.
16.9. Eurofins Genomics
16.10. Eurofins Scientific SE
16.11. GeneCopoeia, Inc.
16.12. GenScript Biotech Corporation
16.13. Horizon Discovery Group Ltd.
16.14. Inscripta Inc.
16.15. Integrated DNA Technologies, Inc.
16.16. Jena Bioscience GmbH
16.17. Merck KGaA
16.18. Origene Technologies, Inc.
16.19. PerkinElmer, Inc.
16.20. Synbio Technologies
16.21. Synthego Corporation
16.22. System Biosciences, LLC
16.23. Takara Bio Inc.
16.24. Thermo Fisher Scientific Inc.
16.25. ToolGen Inc.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Guide RNA Market, Years Considered for the Study
FIGURE 2. Global Guide RNA Market, Research Design
FIGURE 3. Global Guide RNA Market, Research Framework
FIGURE 4. Global Guide RNA Market, Data Triangulation
FIGURE 5. Global Guide RNA Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Guide RNA Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Guide RNA Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Guide RNA Market Size, by Type, 2025 vs 2032 (%)
FIGURE 9. Global Guide RNA Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Guide RNA Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Guide RNA Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Guide RNA Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Guide RNA Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Guide RNA Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Guide RNA Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Guide RNA Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Guide RNA Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Guide RNA Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Guide RNA Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Guide RNA Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Guide RNA Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Guide RNA Market Segmentation & Coverage
TABLE 2. Global Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 3. Global Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global In Vitro Transcription Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global In Vitro Transcription Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global In Vitro Transcription Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 11. Global Activation Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Activation Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Activation Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Interference Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Interference Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Interference Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Single Guide Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Single Guide Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Single Guide Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 21. Global CRISPR/Cas12 Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global CRISPR/Cas12 Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global CRISPR/Cas12 Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global CRISPR/Cas13 Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global CRISPR/Cas13 Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global CRISPR/Cas13 Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global CRISPR/Cas9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global CRISPR/Cas9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global CRISPR/Cas9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 31. Global Gene Editing Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Gene Editing Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Gene Editing Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Gene Regulation Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Gene Regulation Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Gene Regulation Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Gene Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Gene Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Gene Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 41. Global Biopharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Biopharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Biopharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Pharma Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Pharma Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Pharma Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Nonprofit Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Nonprofit Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Nonprofit Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Guide RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Guide RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 71. North America Guide RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. North America Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 73. North America Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 74. North America Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 75. North America Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 76. North America Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 77. North America Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 78. North America Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 79. Latin America Guide RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Latin America Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 81. Latin America Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 82. Latin America Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 83. Latin America Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. Latin America Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Latin America Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 86. Latin America Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 87. Europe Guide RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Europe Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 89. Europe Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 90. Europe Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 91. Europe Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Europe Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Europe Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 94. Europe Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 95. Middle East Guide RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Middle East Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 97. Middle East Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 98. Middle East Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 99. Middle East Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. Middle East Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 101. Middle East Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 102. Middle East Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 103. Africa Guide RNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Africa Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 105. Africa Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 106. Africa Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 107. Africa Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Africa Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Africa Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 110. Africa Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 111. Global Guide RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. ASEAN Guide RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. ASEAN Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 114. ASEAN Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 115. ASEAN Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 116. ASEAN Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. ASEAN Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 118. ASEAN Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 119. ASEAN Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 120. GCC Guide RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. GCC Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 122. GCC Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 123. GCC Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. GCC Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. GCC Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. GCC Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 127. GCC Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 128. European Union Guide RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. European Union Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 130. European Union Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 131. European Union Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. European Union Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. European Union Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. European Union Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 135. European Union Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 136. BRICS Guide RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. BRICS Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 138. BRICS Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 139. BRICS Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 140. BRICS Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. BRICS Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. BRICS Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 143. BRICS Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 144. G7 Guide RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. G7 Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 146. G7 Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 147. G7 Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 148. G7 Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. G7 Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. G7 Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 151. G7 Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 152. NATO Guide RNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. NATO Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 154. NATO Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 155. NATO Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. NATO Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. NATO Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. NATO Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 159. NATO Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 160. Global Guide RNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. United States Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 162. United States Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 163. United States Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 164. United States Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. United States Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. United States Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. United States Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 168. United States Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 169. Canada Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 170. Canada Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 171. Canada Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 172. Canada Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. Canada Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Canada Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. Canada Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 176. Canada Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 177. Mexico Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 178. Mexico Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 179. Mexico Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 180. Mexico Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 181. Mexico Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Mexico Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 183. Mexico Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 184. Mexico Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 185. Brazil Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 186. Brazil Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 187. Brazil Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 188. Brazil Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. Brazil Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. Brazil Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Brazil Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 192. Brazil Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 193. United Kingdom Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 194. United Kingdom Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 195. United Kingdom Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 196. United Kingdom Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 197. United Kingdom Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 198. United Kingdom Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. United Kingdom Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 200. United Kingdom Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 201. Germany Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 202. Germany Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 203. Germany Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 204. Germany Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 205. Germany Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Germany Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Germany Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 208. Germany Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 209. France Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 210. France Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 211. France Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 212. France Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. France Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. France Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. France Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 216. France Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 217. Russia Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 218. Russia Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 219. Russia Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 220. Russia Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. Russia Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. Russia Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Russia Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 224. Russia Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 225. Italy Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 226. Italy Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 227. Italy Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 228. Italy Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 229. Italy Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Italy Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Italy Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 232. Italy Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 233. Spain Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 234. Spain Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 235. Spain Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 236. Spain Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. Spain Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 238. Spain Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. Spain Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 240. Spain Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 241. China Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 242. China Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 243. China Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 244. China Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 245. China Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 246. China Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. China Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 248. China Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 249. India Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 250. India Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 251. India Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 252. India Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. India Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. India Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. India Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 256. India Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 257. Japan Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 258. Japan Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 259. Japan Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 260. Japan Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 261. Japan Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. Japan Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Japan Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 264. Japan Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 265. Australia Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 266. Australia Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 267. Australia Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 268. Australia Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 269. Australia Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. Australia Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. Australia Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 272. Australia Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 273. South Korea Guide RNA Market Size, 2017-2032 (USD Million)
TABLE 274. South Korea Guide RNA Market Size, by Product, 2017-2032 (USD Million)
TABLE 275. South Korea Guide RNA Market Size, by Type, 2017-2032 (USD Million)
TABLE 276. South Korea Guide RNA Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. South Korea Guide RNA Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. South Korea Guide RNA Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. South Korea Guide RNA Market Size, by Biopharma, 2017-2032 (USD Million)
TABLE 280. South Korea Guide RNA Market Size, by Research Institutes, 2017-2032 (USD Million)
TABLE 281. Global Guide RNA Market Share, by Key Player, 2025
TABLE 282. Global Guide RNA Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • Beam Therapeutics Inc.
  • Benchling, Inc.
  • Cellecta Inc.
  • CRISPR Therapeutics AG
  • Dharmacon
  • Editas Medicine, Inc.
  • Eurofins Genomics
  • Eurofins Scientific SE
  • GeneCopoeia, Inc.
  • GenScript Biotech Corporation
  • Horizon Discovery Group Ltd.
  • Inscripta Inc.
  • Integrated DNA Technologies, Inc.
  • Jena Bioscience GmbH
  • Merck KGaA
  • Origene Technologies, Inc.
  • PerkinElmer, Inc.
  • Synbio Technologies
  • Synthego Corporation
  • System Biosciences, LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • ToolGen Inc.

Related Topics

Related Reports

gRNA Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom gRNA Synthesis Services), gRNA Type (Research-use, GPM-grade), Application, End-use, and Region with Growth Forecasts, 2025-2033 - Product Image

gRNA Market Size, Share & Trends Analysis Report by Product & Service (Products, Custom gRNA Synthesis Services), gRNA Type (Research-use, GPM-grade), Application, End-use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 150 Pages
  • Global
From
GRNA - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025-2030) - Product Image

GRNA - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025-2030)

  • Report
  • 110 Pages
  • Global
From
GRNA Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Synthetic gRNA, In-vitro Transcribed (IVT) gRNA, Plasmid-Encoded gRNA Constructs, RNP Complexes (gRNA + Cas), Multiplex gRNA Libraries), Application, End User - Product Image

GRNA Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Synthetic gRNA, In-vitro Transcribed (IVT) gRNA, Plasmid-Encoded gRNA Constructs, RNP Complexes (gRNA + Cas), Multiplex gRNA Libraries), Application, End User

  • Report
  • 160 Pages
  • Global
From
In-vitro Transcription Templates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

In-vitro Transcription Templates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 70 Pages
  • Global
From
RNA Synthesis Market - Global Forecast 2026-2032 - Product Image

RNA Synthesis Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.